Similar articles

• Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system.

  Lyons JS, MacIntyre JC, Lee ME, Carpinello S, Zuber MP, Fazio ML. Lyons JS, et al. Community Ment Health J. 2004 Apr;40(2):101-18. doi: 10.1023/b:comh.0000022731.65054.3e. Community Ment Health J. 2004. PMID: 15206636
• Experiences with Patient Refusal of Off-Label Prescribing of Psychotropic Medications to Children and Adolescents in Japan.

  Tsujii N, Saito T, Izumoto Y, Usami M, Okada T, Negoro H, Iida J. Tsujii N, et al. J Child Adolesc Psychopharmacol. 2016 Sep;26(7):642-5. doi: 10.1089/cap.2014.0131. Epub 2015 Jun 23. J Child Adolesc Psychopharmacol. 2016. PMID: 26103533
• Conflicting data on psychotropic use by children: two pieces to the same puzzle.

  Rubin D. Rubin D. JAMA Pediatr. 2013 Feb;167(2):189-90. doi: 10.1001/jamapediatrics.2013.433. JAMA Pediatr. 2013. PMID: 23403948 No abstract available.
• Use of medication in children with psychiatric disorders.

  Barton R. Barton R. Community Pract. 2007 Nov;80(11):42, 44. Community Pract. 2007. PMID: 18064853 Review.
• Psychotropic drug prescribing: first the good news.

  Keks NA, Burrows GD. Keks NA, et al. Med J Aust. 1999 Apr 5;170(7):293-4. doi: 10.5694/j.1326-5377.1999.tb127778.x. Med J Aust. 1999. PMID: 10327966 Review. No abstract available.